An Australian study involving mice with pancreatic cancer found that the RGS5 gene seems to be associated with blood vessel development in tumors, and mice without the gene survived longer and exhibited 50% tumor shrinkage after being injected with anti-cancer cells. The finding could help alter the tumor environment and make it more vulnerable to therapy, a researcher said.

Full Story:

Related Summaries